Literature DB >> 21145223

Asthma in pregnancy--immunological changes and clinical management.

Lilla Tamási1, Ildikó Horváth, Anikó Bohács, Veronika Müller, György Losonczy, Michael Schatz.   

Abstract

Asthma is one of the most common diseases complicating pregnancy and a risk factor for several maternal and fetal complications, posing a special challenge for physicians treating asthmatic pregnant women. Asthma influences the outcome of pregnancy and - vice versa - pregnancy affects asthma severity with bidirectional immunological interactions that are currently being examined. Supporting pregnancy-induced immunotolerance is the observation that attenuation of allergic responses can be detected in controlled asthmatic pregnant patients. However, uncontrolled asthmatic pregnant women show significant asthma-associated immune reactions, such as diminished pregnancy specific regulatory T cell proliferation, that may - besides other factors - influence fetal growth. Uncontrolled, symptomatic asthma may increase the risk of adverse perinatal outcomes; thus adequate regular anti-asthmatic treatment resulting in optimal asthma control represents a vital need during pregnancy. This review summarizes immunological changes characterizing pregnancy in asthmatic women together with the clinical implications of asthma management during pregnancy. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145223     DOI: 10.1016/j.rmed.2010.11.006

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  9 in total

Review 1.  [Emergency medication during pregnancy].

Authors:  H Fink; S Pildner von Steinburg
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

Review 2.  Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better.

Authors:  Thorbjørn Lomholt Gregersen; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2013-11-15

3.  Case Report of S1Q3T3 Electrocardiographic Abnormality in a Pregnant Asthmatic Patient During Acute Bronchospasm.

Authors:  Hafiza Arshad; Rana Rahel Khan; Misbahuddin Khaja
Journal:  Am J Case Rep       Date:  2017-02-01

Review 4.  Gender aspects and influence of hormones on bronchial asthma - Secondary publication and update.

Authors:  Iris Koper; Karin Hufnagl; Rainer Ehmann
Journal:  World Allergy Organ J       Date:  2017-12-27       Impact factor: 4.084

5.  Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy.

Authors:  Brigitta Dombai; István Ivancsó; András Bikov; Dóra Oroszi; Anikó Bohács; Veronika Müller; János Rigó; Barna Vásárhelyi; György Losonczy; Lilla Tamási
Journal:  Can Respir J       Date:  2017-10-23       Impact factor: 2.409

6.  Parental asthma and risk of autism spectrum disorder in offspring: A population and family-based case-control study.

Authors:  Tong Gong; Cecilia Lundholm; Gustaf Rejnö; Sven Bölte; Henrik Larsson; Brian M D'Onofrio; Paul Lichtenstein; Catarina Almqvist
Journal:  Clin Exp Allergy       Date:  2019-02-27       Impact factor: 5.018

7.  Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy.

Authors:  István Ivancsó; Gergely Toldi; Anikó Bohács; Noémi Eszes; Veronika Müller; János Rigó; Barna Vásárhelyi; György Losonczy; Lilla Tamási
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 8.  Improving asthma during pregnancy with dietary antioxidants: the current evidence.

Authors:  Jessica A Grieger; Lisa G Wood; Vicki L Clifton
Journal:  Nutrients       Date:  2013-08-14       Impact factor: 5.717

9.  Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy.

Authors:  Noémi Eszes; Gergely Toldi; Anikó Bohács; István Ivancsó; Veronika Müller; János Rigó; György Losonczy; Barna Vásárhelyi; Lilla Tamási
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.